ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Ipsos

Ipsos (IPS)

45.82
0.02
(0.04%)
Closed February 01 11:30AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
45.82
Bid
45.40
Ask
47.00
Volume
46,222
45.28 Day's Range 45.82
41.56 52 Week Range 68.20
Market Cap
Previous Close
45.80
Open
45.70
Last Trade
37
@
45.82
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
63,294
Shares Outstanding
43,203,225
Dividend Yield
3.60%
PE Ratio
12.39
Earnings Per Share (EPS)
3.7
Revenue
2.39B
Net Profit
159.73M

About Ipsos

Sector
Advertising Agencies
Industry
Advertising Agencies
Website
Headquarters
Paris, Paris, Fra
Founded
-
Ipsos is listed in the Advertising Agencies sector of the Euronext with ticker IPS. The last closing price for Ipsos was 45.80 €. Over the last year, Ipsos shares have traded in a share price range of 41.56 € to 68.20 €.

Ipsos currently has 43,203,225 shares outstanding. The market capitalization of Ipsos is 1.98 € billion. Ipsos has a price to earnings ratio (PE ratio) of 12.39.

IPS Latest News

Avec l’acquisition de Whereto Research, Ipsos devient le leader des études sociales et gouvernementales en Australie

Avec l’acquisition de Whereto Research, Ipsos devient le leader des études sociales et gouvernementales en Australie Avec l’acquisition de Whereto Research, Ipsos devient le leader des études...

Ipsos becomes the leader of social and government research in Australia with the acquisition of Whereto Research

Ipsos becomes the leader of social and government research in Australia with the acquisition of Whereto Research Ipsos becomes the leader of social and government research in Australia with the...

Ipsos becomes the leader of social and government research in Australia with the acquisition of Whereto Research

Ipsos becomes the leader of social and government research in Australia with the acquisition of Whereto Research Paris, 30 January 2025 - Ipsos, one of the world’s leading market research...

Bilan semestriel du contrat de liquidité IPSOS - Décembre 2024

Bilan semestriel du contrat de liquidité IPSOS - Décembre 2024                                                          28 janvier 2025 Bilan semestriel du contrat de liquidité IPSOS contracté...

Half-year report on IPSOS’ liquidity contract - December 2024

Half-year report on IPSOS’ liquidity contract - December 2024                                                         January 28, 2025 Half-year report on IPSOS’ liquidity contract with Exane BNP...

Ipsos: Disclosure of trading in own shares under a share buyback programme (21 to 24 January 2025)

Ipsos: Disclosure of trading in own shares under a share buyback programme (21 to 24 January 2025) 28 January 2025 Disclosure of trading in own shares under a share buyback programme Period : From...

Ipsos : Communiqué relatif aux rachats d’actions propres (21 au 24 janvier 2025)

Ipsos : Communiqué relatif aux rachats d’actions propres (21 au 24 janvier 2025) Le 28 janvier 2025 Communiqué relatif aux rachats d’actions propres Période du 21 au 24 janvier 2025 Emetteur :...

Ipsos : Déclaration mensuelle d'actions et de droits de vote - Décembre 2024

Ipsos : Déclaration mensuelle d'actions et de droits de vote - Décembre 2024 28 janvier 2025 PUBLICATION MENSUELLE DU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL ET DU NOMBRE TOTAL DE DROITS DE...

Ipsos: Monthly declaration of shares and voting rights - December 2024

Ipsos: Monthly declaration of shares and voting rights - December 2024 January 28, 2025 MONTHLY DISCLOSURE OF THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS Articles L. 233-8 II of the Commercial...

Ipsos successfully completes a bond issuance of €400 million

Ipsos successfully completes a bond issuance of €400 million Ipsos successfully completes a bond issuance of €400 million Paris, 15 January 2025 – Ipsos, one of the world’s leading market research...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.28-0.6073752711546.147.2245.23728545.92222972DE
4-0.44-0.95114569822746.2647.2243.025596744.89965478DE
12-0.62-1.3350559862246.4447.2241.566329444.80539245DE
26-11.68-20.313043478357.55841.565823248.67396811DE
52-15.58-25.374592833961.468.241.565797855.98863939DE
1565.3713.275648949340.4568.236.15604251.58233389DE
26016.2254.797297297329.668.215.825825042.51625054DE

IPS - Frequently Asked Questions (FAQ)

What is the current Ipsos share price?
The current share price of Ipsos is 45.82 €
How many Ipsos shares are in issue?
Ipsos has 43,203,225 shares in issue
What is the market cap of Ipsos?
The market capitalisation of Ipsos is EUR 1.98B
What is the 1 year trading range for Ipsos share price?
Ipsos has traded in the range of 41.56 € to 68.20 € during the past year
What is the PE ratio of Ipsos?
The price to earnings ratio of Ipsos is 12.39
What is the cash to sales ratio of Ipsos?
The cash to sales ratio of Ipsos is 0.83
What is the reporting currency for Ipsos?
Ipsos reports financial results in EUR
What is the latest annual turnover for Ipsos?
The latest annual turnover of Ipsos is EUR 2.39B
What is the latest annual profit for Ipsos?
The latest annual profit of Ipsos is EUR 159.73M
What is the registered address of Ipsos?
The registered address for Ipsos is 35 RUE DU VAL DE MARNE, PARIS, PARIS, 75013
What is the Ipsos website address?
The website address for Ipsos is www.ipsos.com
Which industry sector does Ipsos operate in?
Ipsos operates in the ADVERTISING AGENCIES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALCYBCybergun
0.0002 €
(100.00%)
63.2M
TUVDSBio UV Group DS
0.015 €
(70.45%)
490.92k
CANDCandela Invest
1.70 €
(70.00%)
42
BIODSBiosynex DS
0.07 €
(39.44%)
55.52k
ALGTRGroupe Tera SA
4.10 €
(25.77%)
17.71k
MLIMLImalliance
0.282 €
(-27.32%)
1.5k
ALCARCarmat
0.822 €
(-22.60%)
3.04M
MLOCTOctopus Biosafety
0.14 €
(-21.35%)
18.55k
ALEXPOne Experience
0.386 €
(-21.22%)
933
SNGSonagi
0.80 €
(-20.00%)
800
ATOAtos SE
0.0023 €
(4.55%)
608.11M
ALVERVergnet
0.0011 €
(0.00%)
92.88M
ALCYBCybergun
0.0002 €
(100.00%)
63.2M
BCPBanco Comercial Portugues SA
0.5054 €
(0.04%)
32.95M
ALHPIHopium SA
0.0028 €
(-6.67%)
15.99M

Discussion

View Full Feed
BDEZ BDEZ 3 minutes ago
People are tipping less at restaurants than they have in at least six years, driven by fatigue over rising prices and growing prompts for tips at places where gratuities haven’t historically been expected, per WSJ.
BDEZ BDEZ 3 minutes ago
People are tipping less at restaurants than they have in at least six years, driven by fatigue over rising prices and growing prompts for tips at places where gratuities haven’t historically been expected, per WSJ.
joeycav11 joeycav11 4 minutes ago
If a trial is FDA approved to be initiated.. Then the laws should state that all results have to be posted. This advances all science.
It takes 6 months for a clinical trial to be approved. The results should be published.
NWBO
The Night Stalker The Night Stalker 4 minutes ago
loaded
MCVT
The Night Stalker The Night Stalker 6 minutes ago
bout ready ....... loaded up today
MCVT
gitreal gitreal 6 minutes ago
Those comments are in response to today's video released by NBRI, did you not see it?

https://www.youtube.com/watch?v=6VJ_AMg9CdU

There was no narration but was captioned with this: "Gold concentrate, for shipment to the refinery, produced at the Bishop Gold Mill, Ca
NBRI
janice shell janice shell 7 minutes ago
But what I said make more sense to more people that it doesn't....

On the contrary, that makes no sense at all.
Nebuchadnezzar Nebuchadnezzar 9 minutes ago
~~~~~~~~~~~~~~~~some observations~~~~~~~~~~~~~~~~~~

#1. RITE moved from 0003-0006 range to .0018-0028 range beautifully on above average volume on positive news last 7- 10 trading sessions
#2. bc RITE is still "unsolicited quotes" there are plenty of MM games abound
#3.
RITE
chdobull chdobull 9 minutes ago
ON THE VIDEO BELOW
Click on CC to turn closed caption, click on setting, then click subtitles, then click auto translate and choose english.
The subtitles from the closed caption should now be translated in english for you to read.
Read and try to understand the best you are abl
FBEC
droopyeyes droopyeyes 13 minutes ago
HUGE!
Beautiful sight !!
Too late for cheapies !!

imo 
UMAV
eb0783 eb0783 15 minutes ago
Very nice, Kazzy. Thanks.
"MARAD/USCG – APPROVED, NOT UNDER CONSTRUCTION
MC1. Gulf of Mexico: 1.8 Bcfd (Delfin LNG)"
TGLO
tdbowieknife tdbowieknife 15 minutes ago
regardless, irregardless means pretty much the same thing only with an intensifier...

And yes... Irregardless is a word, as I just spelled it.


..


.
blackcat blackcat 21 minutes ago
Oh. Thanks.
Not likely Not likely 22 minutes ago
Why are you so naive?
SPZI
Perk_Idaho Perk_Idaho 22 minutes ago
I have known you for over 20 years jeeeeeery, since the yahoo message board days, your still playing the same game, and you are still losing. We have locked horns several times... do you remember? The score is 3 to 0, and its about to be 4 to 0, maybe a good time to reconsider how you are playing th
NWBO
norisknorewards norisknorewards 24 minutes ago
"Prob close back in the $0.30s"


Well, you watered down that news more than my dad's vodka in my younger years...

Let's find out next week. It's clearly encouraging.

Shorts will attack a jump, I don't doubt that. I just wonder if they attack it 'le
NWBO
BDEZ BDEZ 25 minutes ago
FBI and the DOJ obstructed the state of FL from investigating Trump’s assassination attempt in Florida

https://x.com/catturd2/status/1885279722252153196
Citrati Citrati 26 minutes ago
What do you mean the pop never comes.
You were posting before the pop and missed 28.70 move 5 years ago. You have been waiting a long time when there has been pop after pop.You missed the $20 move to to 31.50. You missed 13.39 twice,15.24, a 4.90 to 10.45 double, 3.25 to 7.49 double and las
AVXL
Hummingbird2 Hummingbird2 27 minutes ago
https://x.com/GTIIReceiver/status/1885527995596890320?t=rViYaAaMw5ChQWDpGxeXNg&s=19

$FNGR
FNGR
Stock_Barber Stock_Barber 28 minutes ago
Excellent find!

Fuse lit!

Stickied!

👍️
JNSH
3331 3331 30 minutes ago
ACTIPATCH and RECOVERYRX ARE MORE EFFECTIVE (PAIN REDUCTION AND COST) than JOURNAVX!

BIEL competitor VRTX just received FDA approval for JOURNAVX despite it showing essentially no effectiveness in a Phase 2 study for LSR - JOURNAVX showed a mean reduction of 2.02 points on the NPRS at
VRTX

Your Recent History

Delayed Upgrade Clock